WHO ICTRP trial

HEPAfit-Study - Study on the use of pre- and probiotic foods and dietary…

DRKS00025706 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00025706
Public title HEPAfit-Study - Study on the use of pre- and probiotic foods and dietary supplements in the context of medically supervised weight loss programs
Scientific title HEPAfit-Study - Study on the use of pre- and probiotic foods and dietary supplements in the context of medically supervised weight loss programs
Primary sponsor Bodymed AG
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type interventional
Countries Germany
Conditions E66 K76.0;Obesity;Fatty (change of) liver, not elsewhere classified;K76.0
Interventions Group 1: Study group: 14-day liver fasting based on Dr. Worm® and subsequent participation in the Bodymed program with additional administration of the dietary supplements HEPALEAN®, HEPABIOTIC®, SANA-PRO OMEGA-3. After 3 months, switch to…
Registration date Jun 8, 2021
Target size 90
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations